Gothenburg, Västra Götaland County, Sweden
In my current position as a Senior Scientist at AstraZeneca, I work with advanced cell models in the Microphysiological Systems (MPS) team. I joined AstraZeneca in 2022 as a Senior Scientist in the Bioprocessing team within the Cell Therapy department, focusing on the development and delivery of T-cell based therapies for treating autoimmune indications. My background is in pre-clinical cancer research, including practical work within molecular biology and immunology such as cell culture of cancer cells, tumor infiltrating lymphocytes (TILs) and CAR-T cells as well as work with mouse models of cancer. I also have education within good clinical practice (GCP) and good manufacturing practice (GMP) and the experience of working with TIL expansion in a bioreactor (CliniMACS Prodigy from Miltenyi) in a clean room facility at Sahlgrenska University hospital. I received a PhD in Medicine in 2020 from the University of Gothenburg, translating pre-clinical findings to enable future clinical benefit for patients with melanoma. My thesis is entitled "Novel immunotherapies for metastatic melanoma – from mouse models towards clinical trials". During a post-doc at the University of Gothenburg I continued the work started during my PhD as well as expanded the knowledge from melanoma to other indications, mainly pancreatic cancer.
Microphysiological Systems
Cell Therapy
Sahlgrenska Cancer Center, department of Surgery
Sahlgrenska Cancer Center, department of Surgery
Sahlgrenska Cancer Center, department of Biomedicine
Lundberg lab, department of Chemistry and Molecular biology